Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)

NCT05741086 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis

Interventions

DRUG: Evolocumab
DRUG: Atorvastatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University